Weill Cornell
Fresh off its July IPO, the Swiss-American company is expanding its technological and geographical footprints with a series of collaborations and partnerships.
Breast Cancer Genetic Risk Modified by Corticosteroid Use
Some women with an elevated genetic risk of breast cancer, as gauged by a polygenic risk score, might further increase their risk if they also take corticosteroids.
Weill Cornell Medicine Launches $1.5B Program to Advance Medical Research
The funding will be used in part for a precision medicine program that will use genomics, data science, and other technologies to evaluate individual drivers of disease.
Imaging Mass Cytometry Study Reveals Immune Processes Involved in Severe COVID-19
The study's finding suggest that over-stimulation of the complement pathway along with non-specific targeting of lung tissue contribute to death from the virus.
Over the next year or so, the investigators plan to sequence the genomes of 3,000 patients with cancer, heart disease, diabetes, or neurological disorders.